Abstract:Abstract Motivation Chemical–genetic interaction profiling is a genetic approach that quantifies the susceptibility of a set of mutants depleted in specific gene product(s) to a set of chemical compounds. With the recent advances in artificial intelligence, chemical–genetic interaction profiles (CGIPs) can be leveraged to predict mechanism of action of compounds. This can be achieved by using machine learning, where the data from a CGIP is fed into the machine learning platform along with the chemical descriptors to develop a chemogenetically trained model. As small molecules can be considered non-structural data, graph convolutional neural networks, which can learn from the chemical structures directly, can be used to successfully predict molecular properties. Clustering analysis, on the other hand, is a critical approach to get insights into the underlying biological relationships between the gene products in the high-dimensional chemical-genetic data. Methods and results In this study, we proposed a comprehensive framework based on the large-scale chemical-genetics dataset built in Mycobacterium tuberculosis for predicting CGIPs using graph-based deep learning models. Our approach is structured into three parts. First, by matching M. tuberculosis genes with homologous genes in Escherichia coli ( E. coli ) according to their gene products, we grouped the genes into clusters with distinct biological functions. Second, we employed a directed message passing neural network to predict growth inhibition against M. tuberculosis gene clusters using a collection of 50,000 chemicals with the profile. We compared the performance of different baseline models and implemented multi-label tasks in binary classification frameworks. Lastly, we applied the trained model to an externally curated drug set that had experimental results against M. tuberculosis genes to examine the effectiveness of our method. Overall, we demonstrate that our approach effectively created M. tuberculosis gene clusters, and the trained classifier is able to predict activity against essential M. tuberculosis targets with high accuracy. Conclusion This work provides an analytical framework for modeling large-scale chemical-genetic datasets for predicting CGIPs and generating hypothesis about mechanism of action of novel drugs. In addition, this work highlights the importance of graph-based deep neural networks in drug discovery.

Modeling drug mechanism of action with large scale gene-expression profiles using GPAR, an artificial intelligence platform

Gene Expression Profile Prediction under Drug Action Based on Generative Adversarial Networks.

Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Drug Target Prediction Through Deep Learning Functional Representation of Gene Signatures

Deep learning-driven prediction of drug mechanism of action from large-scale chemical-genetic interaction profiles

Discovering the mechanism of action of drugs with a sparse explainable network

Drug discovery and mechanism prediction with explainable graph neural networks

Predicting transcriptional responses to novel chemical perturbations using deep generative model for drug discovery

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

drGAT: Attention-Guided Gene Assessment of Drug Response Utilizing a Drug-Cell-Gene Heterogeneous Network

Accelerating drug repurposing for COVID-19 via modeling drug mechanism of action with large scale gene-expression profiles

Kinome-wide polypharmacology profiling of small molecules by multi-task graph isomorphism network approach

An Enhanced Cascade-Based Deep Forest Model for Drug Combination Prediction

Interpreting the Mechanism of Synergism for Drug Combinations Using Attention-Based Hierarchical Graph Pooling

Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery

Drug - Target Interaction Prediction with a Deep-Learning-based Model.

DeepDRA: Drug repurposing using multi-omics data integration with autoencoders

DrugAI: a multi-view deep learning model for predicting drug-target activating/inhibiting mechanisms

GPDRP: a multimodal framework for drug response prediction with graph transformer

SWnet: a deep learning model for drug response prediction from cancer genomic signatures and compound chemical structures